Kishan AU, Valle LF, Wilhalme H, Felix C, et al. (177)Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025 Nov 12:JCO2501553. doi: 10.1200/JCO-25-01553.
PMID: 41223345